Announcements Trials
Browse Landscape

Phase

Phase 1/2 2

Status

Recruiting 3Active not recruiting 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 10Metastatic Castration-resistant Prostate Cancer 2Prostatic Neoplasms, Castration-Resistant 1Metastatic Hormone Naive Prostate Cancer 1Metastatic Castration Resistant Prostate Cancer (mCRPC) 1Kidney Neoplasms 1Carcinoma, Renal Cell 1

Interventions

olaparib 4Abiraterone Acetate 3Pluvicto 2rucaparib 1radium Ra 223 dichloride 1enzalutamide 1enfortumab vedotin 1copanlisib 1cabazitaxel 1abiraterone 1Radium-223 1Prednisone 1Prednisolone 1Nivolumab 1Androgen Antagonists 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Metastatic Castration-resistant Prostate Cancer × Pluvicto × Clear all
NCT05682443 2026-05-22

PRESERVE-006

OncoC4, Inc.

Phase 1/2 Active not recruiting
148 enrolled
Genitourinary

Metastatic Castration-resistant Prostate Cancer

NCT05340374 2025-04-06

LuCAB

Peter MacCallum Cancer Centre, Australia

Phase 1/2 Active not recruiting
35 enrolled
Genitourinary

Metastatic Castration-resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡